JP Morgan Chase
MED icon

JP Morgan Chase’s Medifast MED Stock Holding History

JP Morgan Chase’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$871K Buy
87,178
+32,798
+60% +$354K ﹤0.01% 4695
2025
Q4 		$581K Buy
54,380
+425
+0.8% +$5.08K ﹤0.01% 4924
2025
Q3 		$738K Buy
53,955
+614
+1% +$8.58K ﹤0.01% 4799
2025
Q2 		$749K Buy
53,341
+1,316
+3% +$17.3K ﹤0.01% 4550
2025
Q1 		$701K Sell
52,025
-65,132
-56% -$978K ﹤0.01% 4575
2024
Q4 		$2.06M Buy
117,157
+59,702
+104% +$1.11M ﹤0.01% 4137
2024
Q3 		$1.1M Buy
57,455
+35,017
+156% +$675K ﹤0.01% 4410
2024
Q2 		$490K Sell
22,438
-2,825
-11% -$75.3K ﹤0.01% 4703
2024
Q1 		$968K Sell
25,263
-45,842
-64% -$2.22M ﹤0.01% 4372
2023
Q4 		$4.78M Sell
71,105
-80,859
-53% -$5.63M ﹤0.01% 3132
2023
Q3 		$11.4M Buy
151,964
+8,402
+6% +$745K ﹤0.01% 2148
2023
Q2 		$13.2M Sell
143,562
-23,110
-14% -$2.06M ﹤0.01% 2045
2023
Q1 		$17.3M Buy
166,672
+46,152
+38% +$5.11M ﹤0.01% 1800
2022
Q4 		$13.9M Buy
120,520
+31,864
+36% +$3.71M ﹤0.01% 1961
2022
Q3 		$9.61M Buy
88,656
+54,943
+163% +$7.87M ﹤0.01% 2175
2022
Q2 		$6.08M Sell
33,713
-4,527
-12% -$810K ﹤0.01% 2608
2022
Q1 		$6.53M Sell
38,240
-10,387
-21% -$1.96M ﹤0.01% 2773
2021
Q4 		$10.2M Buy
48,627
+5,325
+12% +$1.1M ﹤0.01% 2442
2021
Q3 		$8.34M Sell
43,302
-8,914
-17% -$2.19M ﹤0.01% 2550
2021
Q2 		$14.8M Sell
52,216
-8,833
-14% -$2.39M ﹤0.01% 2087
2021
Q1 		$12.9M Buy
61,049
+7,545
+14% +$1.81M ﹤0.01% 2125
2020
Q4 		$10.5M Buy
53,504
+26,243
+96% +$4.64M ﹤0.01% 2180
2020
Q3 		$4.4M Buy
27,261
+4,091
+18% +$674K ﹤0.01% 2678
2020
Q2 		$3.21M Sell
23,170
-11,051
-32% -$1.01M ﹤0.01% 2783
2020
Q1 		$2.14M Sell
34,221
-548
-2% -$49.9K ﹤0.01% 2916
2019
Q4 		$3.81M Sell
34,769
-18,566
-35% -$1.8M ﹤0.01% 2903
2019
Q3 		$5.53M Buy
53,335
+13,838
+35% +$1.49M ﹤0.01% 2624
2019
Q2 		$5.08M Buy
39,497
+1,154
+3% +$160K ﹤0.01% 2640
2019
Q1 		$4.89M Sell
38,343
-5,005
-12% -$635K ﹤0.01% 2607
2018
Q4 		$5.42M Buy
43,348
+10,966
+34% +$1.88M ﹤0.01% 2515
2018
Q3 		$7.17M Sell
32,382
-12,895
-28% -$2.61M ﹤0.01% 2467
2018
Q2 		$7.25M Sell
45,277
-84,488
-65% -$10.8M ﹤0.01% 2396
2018
Q1 		$12.1M Sell
129,765
-22,703
-15% -$1.7M ﹤0.01% 1885
2017
Q4 		$10.6M Sell
152,468
-6,345
-4% -$421K ﹤0.01% 2073
2017
Q3 		$9.47M Buy
158,813
+108,736
+217% +$5.41M ﹤0.01% 2030
2017
Q2 		$2.08M Sell
50,077
-5,405
-10% -$235K ﹤0.01% 3022
2017
Q1 		$2.46M Sell
55,482
-3,306
-6% -$142K ﹤0.01% 2916
2016
Q4 		$2.45M Buy
58,788
+26,541
+82% +$1.07M ﹤0.01% 2938
2016
Q3 		$1.22M Buy
32,247
+123
+0.4% +$4.41K ﹤0.01% 3034
2016
Q2 		$1.07M Buy
32,124
+7,710
+32% +$249K ﹤0.01% 3143
2016
Q1 		$737K Buy
24,414
+550
+2% +$16.1K ﹤0.01% 3193
2015
Q4 		$725K Sell
23,864
-812
-3% -$24.2K ﹤0.01% 3252
2015
Q3 		$663K Buy
24,676
+2,196
+10% +$64K ﹤0.01% 3308
2015
Q2 		$727K Buy
22,480
+650
+3% +$20.6K ﹤0.01% 3429
2015
Q1 		$654K Sell
21,830
-21,447
-50% -$681K ﹤0.01% 3423
2014
Q4 		$1.45M Buy
43,277
+13,982
+48% +$435K ﹤0.01% 3145
2014
Q3 		$962K Buy
29,295
+17,494
+148% +$537K ﹤0.01% 3359
2014
Q2 		$359K Buy
11,801
+2,500
+27% +$77.9K ﹤0.01% 3224
2014
Q1 		$271K Sell
9,301
-14,536
-61% -$389K ﹤0.01% 3328
2013
Q4 		$623K Sell
23,837
-1,897
-7% -$48.6K ﹤0.01% 3373
2013
Q3 		$692K Sell
25,734
-3,735
-13% -$99.9K ﹤0.01% 3482
2013
Q2 		$759K Buy
+29,469
New +$774K ﹤0.01% 3418

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

JP Morgan Chase's MED Position: Q1 2026 in Review

JP Morgan Chase increased its Medifast (MED) stake by 60% in Q1 2026, buying an estimated $354K and bringing the position to 87,178 shares worth $871K. The position accounts for ﹤0.01% of the portfolio, ranked #4695.

JP Morgan Chase first reported a position in MED in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.3M in Q1 2023. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

  • JP Morgan Chase held 87,178 shares of Medifast worth $871K as of Q1 2026.
  • JP Morgan Chase bought 32,798 Medifast shares in Q1 2026, an estimated $354K.
  • Medifast made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4695 holding.
  • JP Morgan Chase first reported a position in Medifast in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Medifast position peaked at $17.3M in Q1 2023.
  • 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.